相关实验视频

Updated: Jan 17, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

皮肤冠状动脉干预在多血管疾病和心脏病发作相关的心脏性休克:一个DanGer休克子研究

Jasmine M Marquard¹, Rasmus P Beske¹, Christian Hassager²

¹Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

JACC. Cardiovascular interventions

|September 24, 2025

概括

在ST段升高心肌梗塞 (STEMI) 患者的立即多血管穿皮冠状动脉干预 (PCI) 患有心脏性休克和多血管疾病,与仅罪祸首的PCI相比,180天死亡率显著降低.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
急性冠状动脉综合征是什么

背景情况:

对ST段升高心肌梗塞 (STEMI) 与心脏性休克和多血管疾病的最佳皮肤冠状动脉干预 (PCI) 策略尚不清楚.
多血管疾病在经历心脏性休克的STEMI患者中很常见.

研究的目的:

调查PCI策略与临床结果之间的关联.
为了比较直接的多血管PCI与STEMI相关心脏病性休克与多血管疾病的罪祸首PCI.

主要方法:

丹格尔冲击多中心试验的探索性子研究.
包括心脏性休克和多血管疾病的STEMI患者 (不包括昏迷患者).
根据处理的PCI策略分析的结果:即时的多容器PCI或仅罪祸首的PCI.

主要成果:

在221名患有多血管疾病的患者中,有118人 (53%) 接受了仅罪祸首的PCI,103人 (47%) 接受了立即的多血管PCI.
180天后所有原因的死亡率仅在罪祸首组为61%,而在直接多血管PCI组中为50%.
立即多血管PCI与所有原因死亡率降低60%的几率有关 (调整后OR:0.40).

结论:

与多血管疾病相关的STEMI相关心脏病性休克中立即多血管PCI与显著降低全因死亡率有关.
只有罪祸首的PCI策略在这个高风险患者群体中显示出更高的死亡率.
进一步的研究可能会证实立即的多船舶PCI作为首选的策略.

关键词:

这就是为什么我们会用声音来表达.心脏发生的冲击是心脏发生的冲击.多艘船的PCI是多艘船的PCI 多血管疾病是多血管疾病.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

相关概念视频

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Blood Pressure Imbalances and Circulatory Shock

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...